14th Annual International Congress on Hematologic Malignancies
March 17 - 21, 2010(Ended)Fairmont Chateau Whistler
Whistler, Canada
Whistler, Canada
The 14th Annual International Congress on Hematologic Malignancies: Focus on Leukemias, Lymphomas, and Myelomas provides a unique opportunity for physicians to learn from and to interact with international leaders in the field of hematologic malignancies in order to increase knowledge, apply new data to practice, and ultimately improve patient outcomes. This international CME-designated congress offers physicians the opportunity to learn about the latest developments in the treatment of hematologic malignancies, including findings presented at recent major oncology conferences, updates on the landscape for new drug indications and new agents, and ongoing clinical trials expected to impact practice in the near future. The instructional format of the congress is varied and includes didactic lectures, panel discussions, debates, and case-based presentations in order to accommodate the different learning styles of the participants. The congress is highly interactive, providing multiple opportunities for faculty-participant interaction. The multiple instructional formats used will enhance the learning experience and foster the integration of evidence-based patient care into everyday community practice. Address
4599 Chateau Boulevard,
Whistler,
Canada
Whistler,
Canada
Prices *
425-2695 US Dollar
Organization
Important
Please, check the conference website for possible changes, before you make any traveling
arrangements
* Prices are for evaluation only.
Articles/News/Press releases
- Effect Of Traditional Egyptian Herbal Medicine on Treatment of Hepatitis C virus (HCV)
- A Study of clinical profile and treatment outcome of DOTS regime in 250 pulmonary and extra pulmonary patients in Hamidia hospital ,Bhopal in the year 2011
- Medical conferences—establishing awareness in medical fields
- Correlation existing between the decreasing values of central corneal thickness and worsening of the field defect in primary open angle glaucoma (Health/Opthalmology)
- Infection Control
- Cancer Basic Research
